Japan Clears First iPSC Therapies for Clinical Use
Two iPSC-derived cell therapies receive time-limited authorization following early clinical trials
03/25/2026
2 min read
False
Advertisement
Related Content
Cell & Gene
Development & Clinical
Interviews
Musings from The Power List: Michael May
September 22, 2026
5 min read
CCRM CEO Michael May on quantum computing, commercialization, and the next era of cell therapy
Development & Clinical
Cell & Gene
Research News
Long-Term Data Boost MCO-010
September 21, 2026
2 min read
Four-year RESTORE results will shed new light on the durability of Nanoscope’s mutation-agnostic optogenetic therapy
Cell & Gene
Industry News
Novartis and BMS Pause Autoimmune CAR T Trials Over Safety Concerns
September 16, 2026
2 min read
Three deaths linked to immune effector cell-associated hemophagocytic syndrome prompt Novartis to halt eight rap-cel studies
Industry News
Research News
Cell & Gene
Personalized Cancer Vaccine Linked to Three-Year Disease-Free Survival in Head and Neck Cancer
September 16, 2026
2 min read
All 16 patients who received TG4050 after standard treatment remained disease-free, compared with 13 of 16 patients in the control group